Emerce, E. Et Al. 2014. A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity. FEBS EMBO 2014 Conference , (Paris, France), 251.

Emerce, E., Cok, İ., & Degim, T., (2014). A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity . FEBS EMBO 2014 Conference (pp.251). Paris, France

Emerce, E., İSMET ÇOK, And T. Degim. "A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity," FEBS EMBO 2014 Conference, Paris, France, 2014

Emerce, E. Et Al. "A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity." FEBS EMBO 2014 Conference , Paris, France, pp.251, 2014

Emerce, E. Cok, İ. And Degim, T. (2014) . "A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity." FEBS EMBO 2014 Conference , Paris, France, p.251.

@conferencepaper{conferencepaper, author={E. Emerce Et Al. }, title={A view to montelukast drug products in terms of impurity regulations: impurities analysis in drug products and in silico/in vitro genotoxicological assessment of sulfoxide impurity}, congress name={FEBS EMBO 2014 Conference}, city={Paris}, country={France}, year={2014}, pages={251} }